Summary: Thirty six individuals with angiographic evidence of coronary atherosclerosis and thirty six individuals without coronary disease, matched for a variety of cardiovascular risk factors including age, sex, smoking, hypertension, diabetes and family history, were evaluated for their serum concentrations of vitamin E, total cholesterol, triacyglycerols, high density lipoprotein-cholesterol, low density lipoprotein-cholesterol, apolipoprotein A-I, and apolipoprotein B. Apolipoprptein B, low density lipoprotein-cholesterol and total cholesterol concentrations were unequivocally higher in patients with coronary artery disease. Triacylglycerols were marginally higher in patients with disease. The antioxidant vitamin E (α-tocopherol) was significantly higher in patients with atherosclerosis when compared with controls (35.1 ± 17.0 μηιοΙ/1 vs. 29.0 ± 13.2 μτηοΐ/l, p = 0.017). However, a-tocopherol concentrations were strongly associated with lipid concentrations and normalization to the total cholesterol concentrations produced ratios which were not significantly different in the two groups. Logistic regression analysis revealed that the association of lipid risk factors with coronary Stenosis was determined primarily by the difference in total cholesterol values. This study demonstrated that in this group of patients referred for angiography and matched for other risk factors, higher α-tocopherol concentrations were associated with patients with coronary disease and were not usefiil for assessing risk of coronary artery disease.
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Materials and Methods

Patients
Three hundred and seventy seven patients referred to the Cleveland Clinic Foundation for coronary angiography were considered for the study. Patients participating in this study signed appropriate informed consent approved by the Institutional Review Board. Coronary artery disease was considered present if greater than 30% of a major vessel was Stenosed and the final diagnosis was coronary artery disease. Coronary artery disease was considered absent only if there was no defmed Stenosis in all vessels. Of this group, 43 males were found to be free of disease and the remaining group of positive patients was evaluated for optimal match of age, sex, smoking history, hypertension, angina, diabetes mellitus, ECG abnormal ities, past myocardial infarction, and family history äs ob-· tained from the medical record. As a result of this process and the availability pf suffkient sample, 36 pairs of matched cases were included för x study for a total of 72 individuals.
Sampling
Serum was obtained at the time of admission for cardiac catheterization, aliquoted and stored frozen at -70 °C until time of analysis except for total cholesterol, triacylglycerols and high density lipoprotein-cholesterol which were determined the day of sample collection. All patients had fasted for at least 12 hours before blood sampling. Whenever possible, the number of separate analytical runs was minimized.
Apolipoprotein assays
Apolipoprotein A-I and apolipoprotein B were measured with an Array nephelometric protein analyzer (Beckman Instruments, Brea CA) with reagents obtained from the manufacturer and according to their instructions.
-Tocopherol assay -Tocopherol was measured using reverse phase high performance liquid chromatography. In brief, 0.5 ml of plasma is combined with an equal volume of a solution of D-a-tocopherol acetate (internal Standard), 25 mg/1 in ethanol, mixed, 1.0 ml of hexane is added, the mixture vortexed for 45 seconds and centrifuged to separate layers. The top layer is removed, evaporated to dryness under nitrogen at room temperature and reconstituted with 200 of mobile phase. Chromatography was carried out using a C-l 8 reverse-phase column (30 cm, Millipore Waters Bondapak, Milford CT) with a C-l8 guard column. System components were all obtained from Millipore Waters. The mobile phase consisted of methanol : water (95 + 5, by vol.), flow rate was 2.5 ml/min and detection was accomplished by measurement of absorbance at 280 nm. Standardization was efTected using a series of Standards prepared by dissolving defüned amounts of -tocopherol and internal Standard in absolute ethanol and comparison of peak height ratios after chromatography in the usual manner. Typical retention times were 2.35 min, 8.82 min and 10.88 min for retinol, -tocopherol and ct-tocopherol acetate respectively.
Lipid assays
Total cholesterol was determined enzymatically with reagents obtained from Boehringer Manheim Diagnostics (Indianapolis, IN) with a Hitachi 717 analyzer according to the manufacturer's protocol. This method was standardized to the National Cholesterol Reference Standard. Triacylglycerols were measured enzymatically with reagents obtained frorn Boehringer; results were corrected for the presence of free glycerol by use of lipase-free blank reagent. High density lipoprotein cholesterol was measured using the dext rän sulfate (M r 50 000) magnesium Chloride precipitation method äs described elsewhere (3) . Cholesterol in high density lipoprotein subfractions were quantified according to the dextran sulfate-magnesium Chloride method described elsewhere (4). Low density lipoprotein and very low density lipoprotein-cholesterol concentrations were calculated from the corresponding triacylglycerols, total chol· esterol and high density lipoprotein-cholesterol concentrations using the Friede wald formal a if triacyglycerol välues were less than 4.57 mmol/1 (4000 mg/1).
Ultracentrifugation
If triacyglycerol välues exceeded 4.57 mmol/1, cholesterol in lipoprotein fractions was estimäted by Ultracentrifugation according to a Standard protocol (5). One ml of serum was added to 4.0 ml of 9.0 g/l sodium Chloride (density = 1.006 kg/l) containing 1.0 g/l sodium ethylenediamine tetracetate in äe ulträcentrifuge tube. The sample was ultracentrifuged for 15 hours at 16°C at 109074g relative centrifugal force. The tube was subsequently placed in a tube cutter and the top 1.5 ml fraction removed volumetrically with a 2.0 ml plastic syringe followed by removal of the lower remaining ftaction after mixing. Cholesterol in the fractions was determined äs described above the very low density and low density lipoprotein-cholesterol concentrations derived after cprrection for recovery.
Statistics
All data distributions were evaluated for normalcy using the Kolmogorov-Smirnov test and non-parametric methods used where appropriate (6) . The Mann-Whitney test for variance was used to compare variables in the group with and without coronary artery disê ase (6) . Probability välues of less than 0.05 were considered signiflcant. Because very low density lipoprotein-cholesterol was calculated from triacyglycerols in the majority of subjects, this variable was considered dependent on triacyglycerols and was not treated separately. Spearman correlation coefficients were calculated (6) . Associations amongst variables were assessed with stepwise multivariate linear regression (6) . Association of signifieant variables with the presence or absence of coronary artery disease was investigated with stepwise logistic regression (7). All statistical analyses were conducted using SYSTAT Software (Evanston, IL) except for logistic regression which was performed using BMDP Software (Berkeley, CA).
Results
The thirty six matched cases used in this study included 10 of 36 with confirmed angina, 31 of 36 with ECG changes, 14 of 36 with hypertension, 4 of 36 diabetes, l of 36 with history of myocardial infarction and 8 of 36 who were currently smoking. Eighteen of 36 padred cases were age matched within one year, 13 of 36 were within 2-5 years and 5 of 36 were within 6-8 years. The average age of the group without coronary artery disease was 50.0 ± 6.0 years and the average age of the group with disease was 51.0 ± 5.5 years and this difference was not significant. The average body mass index [defined äs weight *(kg): height (m^); välues greater than 30 indicate obesity] was similar in both groups (27.9 ± 4.4 kg/m 2 , 28.1 ± 3.7 kg/m 2 , p = 0.66, Mann-Whitney test). All subjects were males. Specific dietary histories were not available for these subjects but there was no evidence in the medical record that any subject was prescribed or was following a low-fat diet or had unusual dietary habits. None of the subjects were taking vitamin E or selenium Supplements and two were taking vitamin C Supplements. Apolipoprotein-B and low density lipoprotein-cholesterol were significantly higher in patients with coronary artery disease, a fmding consistent with most other studies, but vitamin E, generally considered a protectant, was significantly higher in this group s well. To explore this finding further, the correlations between the antioxidants α-tocopherol and the remaining analytes were determined and these are shown iii table 2. Significant correlati ns were obtained between α-tocopherol and total cholesterol, triacyglycerols and the cholesterol fractions.
Stepwise multivariate linear regressi n nalysis revealed that the strongest association of those listed was between Due to the strong association of lipophilic α-tocopherol with lipoprotein particles, it has been suggested that it is more appropriate to express α-tocopherol concentrations in plasma s a ratio to lipoprotein content (1). When mass ratios were calculated using α-tocopherol and total cholesterol concentrations, the average ratio was not significantly different (p = 0.14) in patients without coronary artery disease (6.2 ± 2.9) compared with those with coronary artery disease (6.6 ± 2.7). The mass ratios of α-tocopherol to triacyglycerols were not significant different (8.5 ± 5.1 vs. 7.8 ± 4.1, p = 0.66) s were the ratios of α-tocopherol to low density lipoprotein-cholesterol (9.3 ± 4.3 vs. 9.8 ± 4.8, p = 0.53). Normalization of α-toeopherol concentrations to apolipoprotein concentrations also did not reveal any significant differences between groups.
Logistic regressi n nalysis was performed in a stepwise manner to further assess the association of the risk factors listed in ation. However, when cholesterol was included in the categorical regression model äs a predictor, the independent association of the other risk factors was diminished to insignificance. Therefore, the association of these factors with atherosclerosis in this study group is accounted for by the difference in total cholesterol.
Discussion
The majority of patients who underwent angiography included in this study were referred for catheterization due to either possible cardiac-related ehest pain or abnormal electrocardiograms. The usual lipid values, total cholesterol and triacylglycerols, were known to the referring physician and were usually noted in the review of medical history at the time of angioplasty. Therefore, a subtle selection bias relative to these analyte concentrations cannot be totally ruled out although the average total cholesterol value found in patients without angiography evidence of Stenosis was lower than a mean of 5.75 ± 1.77 mmol/1 observed in 5800 male outpatients seen at our facility for health assessment. It is of interest that the average high density lipoprotein-cholesterol value in patients without coronary disease was relatively low, even when compared with our own mean for 5800 male outpatients (1.13 ±0.31 mmol/1). The significance of this finding remains unclear. High density lipoproteincholesterol was without exception not referenced in the review of patient history and reasons for referral, so although selection bias cannot be ruled out, there is no compelling evidence that it was present with respect to decreased high density lipoprotein-cholesterol values. All patients with hypertension and on medication were case-controlled such that the Overall effect of drugs such äs beta-blockers known to lower high density lipoprotein should be minimal.
-Tocopherol demonstrated a clear significant difference between groups. The difference in -tocopherol concentration is likely due to its association with lipoproteins, äs evidenced by the correlations shown in table 2. This°l eads to significantly higher -tocopherol concentrations in individuals with higher average lipid concentrations, a somewhat counterintuitive finding. Normalization of -tocopherol concentrations to cholesterol, in particular, eliminäted the significance of the difference between groups, although this ratio tended to be higher in patients without coronary Stenosis. A higher ratio of vitamin E to low density lipoprotein-cholesterol, expressed variously on a massrto^molar basis, or a mass-to-mass basis or on a molar-to-molar basis had been suggested to reduce risk of coronary atherosclerosis regardless of cholesterol concentrations (l, 8) . This ratio can also be expressed in terms of apolipoprotein B or lipoprotein protein content. However, We did not observe an increased significance in average values between groups when -tocopherol was expressed äs a ratio to apolipoprotein B rather than to low density lipoprotein-cholesterol.
-Tocopherol is, on a molar basis, the major antioxidant associated with low density lipoprotein (1). Other antioxidants such äs carotenoids, ubiquinol-10 and hydro·? philic antioxidants such äs ascorbic acid are present at much lower concentrations (1) . However, the presence of a given concentration of an antioxidant such äs atocopherol may not accurately reflect the antirpro^oxi-dant Status of a lipoprotein particle. The dynamic interactions occurring amöngst lipoproteins, their constituê nts and the remaining antioxidants and prooxidants in •the circulation are likely to be very coniplex. In vitro, -tocopherol associated with low density lipoprotein has been shown to exchange intermolecularly with estimated half-lifes of 20-70 min (9) . This study did not attempt to assess the associated lipid peröxide coneentrations although this determination may aid in the Identification . of excess oxidative modification of low density lipoprotein in patients with coronary artery disease.
It is important to note that the association of vitamin E with reduced risk of cardiac disease is strengthened by supplementation of the usual dietary iratake (10) . In addition, there is evidence that this supplementation must exceed a threshold before protective effects are ächieved (l, 11). The data obtained here on a group of men not taking vitamin E Supplements suppoft this nötation by failing to exhibit significantly higher -tocopherol concentrations or ratios to lipid concentrations in the absence of coronary artery disease. We could not ascertain the effect of dietary vitamin E on this association and, thus, it cannot be ruled out. The confirmation of the Utility of measurement of this antioxidant in serum or plasma will probably require further prospective evaluation of patients receiving significant vitamin E supplementation, in a diet-controlled Situation.
In conclusion, this study dempnstrates that a-tocöpherol concentrations may be aetually increased in patients with coronary artery disease due to its association with increased concentrations of lipoproteins. This study also confirmed the relevance of an increased total cholesterol concentration to the presence of coronary artery disease when other clinical factors are controlled. Apolipoprotein B and low density lipoprotein-cholesterol were also increased significantly in patients with coronary artery disease. The remaining risk factors analyzed did not achieve significance and their relevance could not be validated. Expressing vitamin E äs a mass ratio eliminated the significance of the difference observed between groups. Therefore, although oxidative modification of low density lipoprotein may be important in the development of atheroslcerosis the measurement of total atocopherol in serum does not provide useful Information regarding its potential role äs a preventive antioxidant.
